Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$692.74+5.95 (+0.87%)
Close on Nov 18, 2026Market cap $256.67BP/E 36.6Yield 0.25%
Thermo Fisher Scientific free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Thermo Fisher Scientific's free cash flow for the twelve months ending Sep 26, 2026 was $7.60B, up 24.3% year over year. For fiscal 2025 it was $6.29B, down 13.4% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $7.27B in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.29B | -13.4% |
| FY2024 | Dec 31, 2024 | $7.27B | +4.9% |
| FY2023 | Dec 31, 2023 | $6.93B | +0.2% |
| FY2022 | Dec 31, 2022 | $6.91B | +1.8% |
| FY2021 | Dec 31, 2021 | $6.79B | -0.4% |
| FY2020 | Dec 31, 2020 | $6.82B | +68.4% |
| FY2019 | Dec 31, 2019 | $4.05B | +6.9% |
| FY2018 | Dec 31, 2018 | $3.79B | +8.2% |
| FY2017 | Dec 31, 2017 | $3.50B | +24.3% |
| FY2016 | Dec 31, 2016 | $2.81B | +11.7% |
| FY2015 | Dec 31, 2015 | $2.52B | +14.9% |
| FY2014 | Dec 31, 2014 | $2.19B | +26.8% |
| FY2013 | Dec 31, 2013 | $1.73B | +0.2% |
| FY2012 | Dec 31, 2012 | $1.72B | +20.6% |
| FY2011 | Dec 31, 2011 | $1.43B | +14.2% |
| FY2010 | Dec 31, 2010 | $1.25B | -14.2% |
| FY2009 | Dec 31, 2009 | $1.46B | +26.3% |
| FY2008 | Dec 31, 2008 | $1.16B | -11.6% |
| FY2007 | Dec 31, 2007 | $1.31B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $2.11B | +15.1% |
| Q2 FY2026 | Jun 27, 2026 | $1.68B | +51.6% |
| Q1 FY2026 | Mar 28, 2026 | $816.00M | +126.0% |
| Q4 FY2025 | Dec 31, 2025 | $2.99B | +6.5% |
| Q3 FY2025 | Sep 27, 2025 | $1.84B | -3.1% |
| Q2 FY2025 | Jun 28, 2025 | $1.11B | -33.4% |
| Q1 FY2025 | Mar 29, 2025 | $361.00M | -60.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.81B | -15.3% |
| Q3 FY2024 | Sep 28, 2024 | $1.89B | -9.0% |
| Q2 FY2024 | Jun 29, 2024 | $1.66B | +32.1% |
| Q1 FY2024 | Mar 30, 2024 | $904.00M | +233.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.32B | +13.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.08B | +49.8% |
| Q2 FY2023 | Jul 1, 2023 | $1.26B | +22.9% |
| Q1 FY2023 | Apr 1, 2023 | $271.00M | -82.7% |
| Q4 FY2022 | Dec 31, 2022 | $2.94B | +80.6% |
| Q3 FY2022 | Oct 1, 2022 | $1.39B | -34.6% |
| Q2 FY2022 | Jul 2, 2022 | $1.02B | -39.4% |
| Q1 FY2022 | Apr 2, 2022 | $1.56B | +15.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.63B | -40.9% |
| Q3 FY2021 | Oct 2, 2021 | $2.13B | -9.2% |
| Q2 FY2021 | Jul 3, 2021 | $1.69B | +4.3% |
| Q1 FY2021 | Apr 3, 2021 | $1.35B | +1210.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.75B | +69.5% |
| Q3 FY2020 | Sep 26, 2020 | $2.34B | +159.9% |
| Q2 FY2020 | Jun 27, 2020 | $1.62B | +50.6% |
| Q1 FY2020 | Mar 28, 2020 | $103.00M | -77.0% |
| Q4 FY2019 | Dec 31, 2019 | $1.62B | +7.1% |
| Q3 FY2019 | Sep 28, 2019 | $901.00M | -13.9% |
| Q2 FY2019 | Jun 29, 2019 | $1.07B | -14.8% |
| Q1 FY2019 | Mar 30, 2019 | $448.00M | – |
| Q4 FY2018 | Dec 31, 2018 | $1.52B | -8.1% |
| Q3 FY2018 | Sep 29, 2018 | $1.05B | +28.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.26B | +65.7% |
| Q1 FY2018 | Mar 31, 2018 | -$40.00M | -114.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.65B | +54.0% |
| Q3 FY2017 | Sep 30, 2017 | $817.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $761.00M | – |
| Q1 FY2017 | Apr 1, 2017 | $268.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.07B | – |
See a number that looks wrong?